These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23711897)

  • 1. [Prevalence of hypertension in El-Menia oasis, Algeria, and metabolic characteristics in population].
    Hamida F; Atif ML; Temmar M; Chibane A; Bezzaoucha A; Bouafia MT
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):172-8. PubMed ID: 23711897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of hypertension in the Algerian Sahara.
    Temmar M; Labat C; Benkhedda S; Charifi M; Thomas F; Bouafia MT; Bean K; Darne B; Safar ME; Benetos A
    J Hypertens; 2007 Nov; 25(11):2218-26. PubMed ID: 17921815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in prevalence, treatment and control rates of hypertension between male and female in the area of Blida (Algeria).
    Bachir Cherif A; Bouamra A; Taleb A; Nedjar R; Bouraghda A; Hamida F; Temmar M; Bouafia MT
    Ann Cardiol Angeiol (Paris); 2017 Jun; 66(3):123-129. PubMed ID: 28554703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risk factors in Algeria. Analysis of the subgroup from the "Africa/Middle East Cardiovascular Epidemiological" Study].
    Brouri M; Ouadahi N; Nibouche D; Benabbas Y; El Hassar M; Bouraoui S; Abad N; Abreu PC; Ikardouchene L
    Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):61-66. PubMed ID: 29530274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey.
    Oladapo OO; Salako L; Sodiq O; Shoyinka K; Adedapo K; Falase AO
    Cardiovasc J Afr; 2010; 21(1):26-31. PubMed ID: 20224842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, awareness, treatment, and control of hypertension among people over 40 years old in a rural area of South Korea: The Chungju Metabolic Disease Cohort (CMC) Study.
    Lee HS; Park YM; Kwon HS; Lee JH; Park YJ; Lim SY; Lee SH; Yoon KH; Son HY; Kim DS; Yim HW; Lee WC
    Clin Exp Hypertens; 2010 May; 32(3):166-78. PubMed ID: 20504124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly.
    Redón J; Cea-Calvo L; Moreno B; Monereo S; Gil-Guillén V; Lozano JV; Martí-Canales JC; Llisterri JL; Aznar J; Fernández-Pérez C;
    J Hypertens; 2008 Sep; 26(9):1757-64. PubMed ID: 18698209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study.
    Snijder MB; Zimmet PZ; Visser M; Dekker JM; Seidell JC; Shaw JE
    Int J Obes Relat Metab Disord; 2004 Mar; 28(3):402-9. PubMed ID: 14724659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total and abdominal obesity among rural Chinese women and the association with hypertension.
    Zhang X; Yao S; Sun G; Yu S; Sun Z; Zheng L; Xu C; Li J; Sun Y
    Nutrition; 2012 Jan; 28(1):46-52. PubMed ID: 21621392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal)].
    Pessinaba S; Mbaye A; Yabéta GA; Harouna H; Sib AE; Kane AD; Bodian M; Ndiaye MB; Mbaye-Ndour M; Niang K; Diagne-Sow D; Diack B; Kane M; Diao M; Mathieu JB; Kane A
    Ann Cardiol Angeiol (Paris); 2013 Aug; 62(4):253-8. PubMed ID: 23540763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey.
    Camara A; Baldé NM; Diakité M; Sylla D; Baldé EH; Kengne AP; Baldé MD
    J Hum Hypertens; 2016 Apr; 30(4):237-44. PubMed ID: 26310186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study.
    Feldstein CA; Akopian M; Olivieri AO; Kramer AP; Nasi M; Garrido D
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):310-5. PubMed ID: 16054556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study.
    Mancia G; Parati G; Borghi C; Ghironzi G; Andriani E; Marinelli L; Valentini M; Tessari F; Ambrosioni E;
    J Hypertens; 2006 May; 24(5):837-43. PubMed ID: 16612244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects.
    Anari R; Amani R; Latifi SM; Veissi M; Shahbazian H
    Diabetes Metab Syndr; 2017; 11(1):37-41. PubMed ID: 27477531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects.
    Rantala AO; Kauma H; Lilja M; Savolainen MJ; Reunanen A; Kesäniemi YA
    J Intern Med; 1999 Feb; 245(2):163-74. PubMed ID: 10081519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.